Recombination Therapeutics
Biotechnology Research
3 employees
- Employees
- 3
- Contacts
- 1
- Emails
- 1
- Phones
- 1
Recombination Therapeutics Overview
- Website
- www.recombinationtx.com
- Industry
- Biotechnology Research
- Employees
- 3
- Founded
- 2018
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Recombination Therapeutics
Recombination Therapeutics is a preclinical DNA Damage Response (DDR) biotechnology company focused on developing best-in-class personalized cancer therapeutics. Recombination Therapeutics was established with the goal of developing next-generation precision medicines for cancers with genetic defects in the DNA repair pathway called homologous recombination. Recombination’s lead program is targeting DNA polymerase Theta (Polq) which is essential for the proliferation of recombination deficient cancer cells, but is dispensable for normal cells.
Recombination Therapeutics Contact Details
- People in AeroLeads
- 2
- With contact data
- 1
- Email contacts
- 1
- 50.0% coverage
- Phone contacts
- 1
- 50.0% coverage
Recombination Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Richard Pomerantz | Cofounder and Cso Recombination | United States |
View
|
| John Oates | Philadelphia, Pennsylvania, United States |
Email
Phone
|
Compare Similar Companies to Recombination Therapeutics
Higher Medicine
Biotechnology Research
Eldari Bio
Software Development
ReEngage Therapeutics
Biotechnology Research
SpaceRx
Biotechnology Research
Vertical Longevity Pharmaceuticals
Biotechnology Research
Chariot Biosciences
Biotechnology Research
Combined Ingenuity
Technology, Information And Internet
Exin BioPharma Inc.
Biotechnology Research
QuneUp®
Software Development
Red Ace Bio
Biotechnology Research